TABLE OF CONTENTS

1. INTRODUCTION6
2. STANDARD REQUIREMENTS FOR TRAINING IN MEDICAL ONCOLOGY7
3. SPECIAL REQUIREMENTS7
3.1 Programme Leader/Director of Medical Oncology Training Programme7
3.2. Faculty8
3.2.1 Faculty members8
3.2.2 Faculty standards8
3.3 Educational Programme8
3.3.1 Educational environment8
3.3.2 Professionalism8
3.3.3 Responsibility8
3.3.4 Update of skills and knowledge8
3.3.5 Perception of other specialties8
3.3.6 Institutional requirements8
3.3.6.a Clinical setting8
3.3.6.b Hospital facilities8
3.3.7 Facilities9
4. COMPETENCIES REQUIRED IN THE CURRICULUM9
4.1 Basic Scientific Principles9
4.1.1 Cancer biology9
4.1.2 Tumour immunology10
4.1.3 Aetiology, epidemiology, screening and prevention11
4.1.4 Clinical research12
4.1.5 Statistics13
4.2 Basic Principles in the Management and Treatment of Malignant Diseases14
4.2.1 Pathology14
4.2.2 Molecular pathology15
4.2.3 Laboratory medicine17
4.2.4 Translational research18
4.2.5 Principles of personalised cancer medicine19
4.2.6 Staging procedures (clinical staging)20
4.2.7 Imaging21
4.2.8 Molecular imaging22
4.2.9 RECIST22
4.3 Therapy23
4.3.1 Surgical oncology23
4.3.2 Radiation oncology24
4.3.3 Anticancer agents25
4.3.4 Biological therapy26
4.3.5 Immunotherapy27
4.3.6 Complications/Toxicities of treatment28
4.4 Supportive and Palliative Care29
4.4.1 Supportive measures29
4.4.2 Palliative care33
4.4.3 End-of-life care34
4.5 Management and Treatment of Specific Cancers35
4.5.1 Head and neck cancers37
4.5.2 Thoracic malignancies38
4.5.2.a Small-cell lung cancer38
4.5.2.b Non-small-cell lung cancer39
4.5.2.c Mesothelioma40
4.5.2.d Thymoma and thymic cancer40
4.5.3 Gastrointestinal cancers41
4.5.3.a Oesophageal cancer41
4.5.3.b Gastric cancer42
4.5.3.c Colon and rectal cancer44
4.5.3.d Anal cancer45
4.5.3.e Hepatobiliary cancers46
4.5.3.f Pancreatic adenocarcinoma47
4.5.4 Genitourinary cancers48
4.5.4.a Renal cell cancer48
4.5.4.b Urothelial cancer49
4.5.4.c Penile cancer51
4.5.4.d Prostate cancer52
4.5.4.e Germ cell tumours53
4.5.5 Gynaecological malignancies55
4.5.5.a Ovarian cancer (including Fallopian tube and primary peritoneal cancer)55
4.5.5.b Endometrial cancer56
4.5.5.c Cervical cancer57
4.5.5.d Vulvar and vaginal cancers58
4.5.5.e Gestational trophoblastic neoplasia59
4.5.6 Breast cancer59
4.5.7 Sarcomas61
4.5.7.a Bone sarcomas61
4.5.7.b Soft tissue sarcomas62
4.5.7.c Gastrointestinal stromal tumour63
4.5.8 Skin cancers63
4.5.8.a Melanoma63
4.5.8.b Basal cell and squamous cell cancers of the skin65
4.5.9 Endocrine tumours66
4.5.9.a Thyroid cancer66
4.5.9.b Neuroendocrine neoplasms66
4.5.10 Central nervous system malignancies67
4.5.11 Carcinoma of unknown primary site69
4.5.12 Haematological malignancies70
4.5.12.a Leukaemias (including acute and chronic leukaemias of lymphoid and myeloid lineage)70
4.5.12.b Lymphomas71
4.5.12.b.1 Hodgkin's lymphoma71
4.5.12.b.2 Non-Hodgkin's lymphoma72
4.5.12.c Plasma cell dyscrasias73
4.5.12.d Myeloproliferative neoplasms74
4.6 Rare Cancers75
4.7 AIDS-Associated Malignancies76
4.8 Special Issues in the Diagnosis and Treatment of Cancers in Adolescents77
4.9 Special Issues in the Diagnosis and Treatment of Cancers in Young Adults78
4.10 Cancer and Pregnancy79
4.11 Geriatric Oncology80
4.12 Cancer Treatment in Patients with Comorbidities81
5. PSYCHOSOCIAL ASPECTS OF CANCER82
6. COMMUNICATION84
7. GENETIC COUNSELLING85
8. PATIENT EDUCATION85
9. SURVIVORSHIP86
10. BIOETHICAL, LEGAL AND ECONOMIC ISSUES88
10.1 Bioethical and Legal Issues88
10.2 Economic Issues of New Cancer Drugs89
11. CANCER CARE DELIVERY IN LOW RESOURCE ENVIRONMENTS90
12. SKILLS90